Related Experiment Video
Updated: May 21, 2026

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations
Paolo Curatolo1, Sergiusz Jóźwiak, Rima Nabbout
1Department of Neurosciences, Pediatric Neurology Unit, Tor Vergata University, via Montpellier 1, 00133 Rome, Italy. curatolo@uniroma2.it
Insights
Tuberous sclerosis complex (TSC) epilepsy is a genetic condition causing early-life seizures and cognitive issues. Management remains challenging, with many patients experiencing persistent seizures despite current treatments.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Tuberous sclerosis complex (TSC) is a significant genetic cause of epilepsy, often manifesting in infancy.
- TSC-associated epilepsy is linked to neurodevelopmental and cognitive impairments.
- Current management strategies for TSC epilepsy present considerable challenges, with persistent seizures common.
Purpose of the Study:
- To summarize clinical recommendations for managing TSC-associated epilepsy.
- To outline current treatment options and identify areas for future research.
- To provide guidance based on a European expert panel consensus from March 2012.
Main Methods:
- A panel of European experts convened in March 2012.
- The panel discussed and formulated clinical recommendations for TSC-associated epilepsy management.
- The report synthesizes current treatment options and highlights outstanding questions.
Main Results:
- The report provides a summary of clinical recommendations for TSC-associated epilepsy.
- It outlines existing pharmacological and surgical treatment options.
- Key challenges and areas needing further investigation are identified.
Conclusions:
- Management of TSC-associated epilepsy requires specialized approaches due to its complexity.
- Despite available treatments, seizure control remains a significant challenge for many patients.
- Further research is needed to address outstanding questions in TSC epilepsy management.
Abstract:
Tuberous sclerosis complex (TSC) is a leading genetic cause of epilepsy. TSC-associated epilepsy generally begins during the first year of life, and is associated with neurodevelopmental and cognitive problems. Management is challenging and seizures tend to persist in a large proportion of patients despite pharmacological and surgical treatment. This report summarizes the clinical recommendations for the management of TSC-associated epilepsy made by a panel of European experts in March 2012. Current treatment options and outstanding questions are outlined.
More Related Videos
11:29Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Epilepsy ll: Types
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Seizures l: Introduction
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: